Author

Wei Xiong

Loma Linda UniversityORCID 0000-0003-1635-8173Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andrew A. FarmeriD· 1 shared Bin Zhu· 1 shared Charles WangiD· 1 shared Christopher E. MasoniD· 1 shared Chunlin XiaoiD· 1 shared Feng ZengiD· 1 shared Hao ZhuiD· 1 shared Hongjin Wu· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Andrew A. FarmerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsPrecision Clinical MedicinePeer-reviewedApr 9, 2025

A benchmarking study of copy number variation inference methods using single-cell RNA-sequencing data

Xin Chen, Li Tai Fang, Zhong Chen…·Charles Wang

This study benchmarks five scCNV inference methods across multiple scRNA-seq platforms and mixed samples, finding variations in performance based on data characteristics and batch effects.

9 citations

humanscRNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintJul 13, 2024

Many erroneous noncoding transcripts in cancer cells can highly specifically regulate cancer-related genes and pathways

Sha He, Wei Xiong, Jian-Ping Huo…·Hao Zhu

The paper identifies erroneous noncoding transcripts in cancer cells and shows they can specifically regulate cancer-related genes and pathways, suggesting new therapeutic targets.

DOI 10.1101/2024.07.13.603398

humanbulk RNA-seq

𝕏 PostBluesky